Validation of the Paris (Functional Coccydynia Effect) Pain Questionnaire
Coccydynia
1 other identifier
observational
105
1 country
1
Brief Summary
This study aims to validate and assess the reliability of the Turkish version of the Paris Pain Questionnaire (PPQ) in patients with coccydynia. The PPQ was developed by Dr. Jean-Yves Maigne as a condition-specific tool to evaluate pain severity and functional limitations in individuals with coccydynia. This study follows a cross-sectional observational design and includes 105 participants. The psychometric properties of the Turkish version will be assessed through internal consistency (Cronbach's alpha), test-retest reliability (intraclass correlation coefficient - ICC), and construct validity. The results will determine whether the PPQ is a valid and reliable tool for use in Turkish-speaking populations with coccydynia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 30, 2024
CompletedFirst Submitted
Initial submission to the registry
February 21, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 21, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 21, 2025
CompletedFirst Posted
Study publicly available on registry
February 26, 2025
CompletedMarch 5, 2025
March 1, 2025
4 months
February 21, 2025
March 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Internal Consistency (Cronbach's Alpha)
Internal consistency of the Turkish PPQ will be assessed using Cronbach's alpha.
Baseline
Test-Retest Reliability (ICC)
Intraclass correlation coefficient (ICC) will be calculated to assess reliability over time.
Baseline and 3-day follow-up
Secondary Outcomes (2)
Construct Validity (Pearson Correlation)
Baseline
Factor Analysis
Baseline
Eligibility Criteria
Diagnosed with coccydynia
You may qualify if:
- Age: 18 to 65 years
- Diagnosis of coccydynia confirmed through clinical and radiological evaluation
- Ability to read and understand Turkish
- Willingness to participate and provide informed consent
You may not qualify if:
- Presence of other conditions causing pelvic or rectal pain (e.g., endometriosis, ectopic pregnancy, hemorrhoids, rectal carcinoma)
- Severe psychiatric disorders (e.g., psychosis, major depression within the last 30 days)
- Neurological disorders affecting the pelvic region or lower back
- History of surgery or trauma to the coccygeal area within the past 90 days
- Primary complaints of low back pain rather than coccydynia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fatih Sultan Mehmet Training and Research Hospital
Istanbul, 34098, Turkey (Türkiye)
Study Officials
- PRINCIPAL INVESTIGATOR
Aslinur Keles Ercisli, M. D.
Fatih Sultan Mehmet Training and Research Hospital
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 2 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
February 21, 2025
First Posted
February 26, 2025
Study Start
October 30, 2024
Primary Completion
February 21, 2025
Study Completion
February 21, 2025
Last Updated
March 5, 2025
Record last verified: 2025-03